St. Johns Investment Management Company LLC Has $598,000 Stock Position in CVS Health Corporation $CVS

St. Johns Investment Management Company LLC reduced its holdings in shares of CVS Health Corporation (NYSE:CVS) by 7.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,665 shares of the pharmacy operator’s stock after selling 735 shares during the quarter. St. Johns Investment Management Company LLC’s holdings in CVS Health were worth $598,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the company. Wallace Advisory Group LLC grew its position in CVS Health by 11.2% in the 2nd quarter. Wallace Advisory Group LLC now owns 9,833 shares of the pharmacy operator’s stock worth $666,000 after purchasing an additional 988 shares in the last quarter. Greenup Street Wealth Management LLC grew its position in CVS Health by 2.3% in the 2nd quarter. Greenup Street Wealth Management LLC now owns 18,050 shares of the pharmacy operator’s stock worth $1,245,000 after purchasing an additional 411 shares in the last quarter. VCI Wealth Management LLC grew its position in CVS Health by 14.1% in the 2nd quarter. VCI Wealth Management LLC now owns 17,756 shares of the pharmacy operator’s stock worth $1,225,000 after purchasing an additional 2,197 shares in the last quarter. Avidian Wealth Enterprises LLC grew its position in CVS Health by 100.2% in the 2nd quarter. Avidian Wealth Enterprises LLC now owns 6,071 shares of the pharmacy operator’s stock worth $419,000 after purchasing an additional 3,038 shares in the last quarter. Finally, Lyell Wealth Management LP purchased a new position in CVS Health in the second quarter valued at about $212,000. 80.66% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.22% of the stock is owned by insiders.

CVS Health Price Performance

Shares of NYSE:CVS opened at $83.06 on Wednesday. The company’s fifty day moving average price is $74.70 and its 200-day moving average price is $68.36. The firm has a market capitalization of $105.34 billion, a price-to-earnings ratio of 23.20, a PEG ratio of 0.91 and a beta of 0.60. CVS Health Corporation has a one year low of $43.56 and a one year high of $83.52. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion for the quarter, compared to analyst estimates of $94.87 billion. During the same quarter in the prior year, the firm earned $1.83 EPS. The business’s revenue for the quarter was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.2%. CVS Health’s dividend payout ratio is presently 74.30%.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Wells Fargo & Company upped their price target on shares of CVS Health from $84.00 to $103.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Morgan Stanley upped their price target on shares of CVS Health from $82.00 to $89.00 and gave the company an “overweight” rating in a research note on Tuesday, October 14th. Leerink Partners upped their price target on shares of CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 16th. Jefferies Financial Group upped their target price on shares of CVS Health from $80.00 to $92.00 in a report on Wednesday, October 15th. Finally, Mizuho upped their target price on shares of CVS Health from $76.00 to $88.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $82.57.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.